University of Heidelberg
Beset by COVID-19 Pandemic, Europe Searches for Right Test Mix for Diagnosis, Surveillance
Some parts of Europe turned to serology testing early to try to get a handle on the pandemic but had to quickly pull back after those tests performed abysmally.
The method uses nanopore sequencing to analyze short cell-free DNA fragments from blood, providing results in as little as six hours.
In a recent publication, the researchers assessed clinical data from 3,000 late-stage NSCLC patients after performing DNA and RNA sequencing on their tissue samples.
Heidelberg Cancer Collaboration Enables Targeted and Comprehensive Molecular Tumor Profiling
Premium
A partnership involving Heidelberg University Hospital, the National Center for Tumor Diseases, and the German Cancer Research Institute is serving patients across Germany.